SESSION XI: MANTLE CELL LYMPHOMA

Session Chairs: Nina Wagner-Johnston and Krish Patel

What Is the Role of BTKi in the Frontline Treatment of Mantle Cell Lymphoma? | Nina D Wagner-Johnston, MD | Johns Hopkins University, Baltimore, Maryland, USA

Sequencing Therapies in Relapsed/Refractory Mantle Cell Lymphoma | Craig Portell, MD | University of Virginia, Charlottesville, Virginia, USA

Novel Investigational Agents for the Treatment of MCL | Krish Patel, MD | Providence Swedish Cancer Institute, Seattle, Washington, USA

Accessing BTKi’s and Other Novel Therapies for Mantle Cell Lymphoma | Guilherme F Perini, MD | Hospital Israelita Albert Einstein, Sao Paulo, Brazil